Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Dermoscopy can help diagnose tuberous sclerosis by identifying unique skin patterns.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Hidradenitis suppurativa may be a type of autoinflammatory skin disease linked to gene mutations and immune system issues.

The patient improved after antiviral treatment for a viral infection.

Different types of skin cells and immune cells play a role in healing UV-damaged skin, with chronic UV exposure causing lasting damage to certain skin cells.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

A Chinese male with a new genetic mutation has a skin condition and severe urinary issues, with treatments having mixed success.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Recognizing and treating overlap syndrome in connective tissue diseases is crucial.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

A rare, benign facial tumor called fibrofolliculoma was successfully treated with surgery.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Scarring folliculitis type of acne inversa is linked to specific symptoms and lifestyle factors like smoking and being overweight.

Trichothiodystrophy causes abnormal protein deposits and distortion in hair follicles.